Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M81.8Revenue $M0Net Margin (%)0Z-Score0.5
Enterprise Value $M51.2EPS $-1.3Operating Margin %0F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %-10.1Quick Ratio22.7Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %1.3Current Ratio22.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-60.2Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)4ROE % (ttm)-92.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M22.1ROI % (ttm)-7,524.8Gross Margin Increase y-yN

Gurus Latest Trades with GALT

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GALTGeorge Soros 2014-06-30 Sold Out -0.01%$10.23 - $14.81
($12.43)
$ 3.7-70%Sold Out0
GALTGeorge Soros 2014-03-31 Buy 0.01%$8.025 - $18.3
($14.02)
$ 3.7-74%New holding, 48200 sh.48,200
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GALT is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


GALT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Greenberg ArthurDirector 2014-08-19Buy1,000$4.56-22.15view
FREEMAN KEVIN DDirector 2014-08-15Buy1,000$4.7-24.47view
TRABER PETER GPresident and CEO 2014-08-14Buy4,000$4.46-20.4view
CALLICUTT JACK WCFO 2014-08-14Buy1,000$4.55-21.98view
TRABER PETER GPresident and CEO 2014-08-13Buy1,000$4.42-19.68view
Prelack StevenDirector 2014-04-11Sell6,000$11.84-70.02view
10X Fund, L.P.10% Owner 2014-01-13Sell100,000$14.84-76.08view
CZIRR JAMES CExecutive Chairman 2014-01-13Sell100,000$14.84-76.08view
Martin Rod DDirector 2014-01-13Sell100,000$14.84-76.08view
MAULDIN JOHN FDirector 2014-01-02Buy618$8.01-55.68view

Press Releases about GALT :

    Quarterly/Annual Reports about GALT:

    News about GALT:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Nasdaq stocks posting largest percentage increases Dec 16 2014
    GALECTIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Dec 12 2014
    Galectin Therapeutics to Present at 7th Annual LD Micro Main Event Conference Dec 01 2014
    Galectin Therapeutics to Present at 7th Annual LD Micro Main Event Conference Dec 01 2014
    GALECTIN THERAPEUTICS INC Financials Nov 18 2014
    GALECTIN THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 10 2014
    GALECTIN THERAPEUTICS INC Files SEC form 10-Q, Quarterly Report Nov 10 2014
    Galectin Therapeutics Reports Third Quarter 2014 Financial Results and Provides Update on Company's... Nov 10 2014
    Galectin Therapeutics' Phase 1 Data Presented at AASLD Annual Meeting Advances GR-MD-02 Into Phase 2... Nov 09 2014
    Galectin Therapeutics' Phase 1 Data Presented at AASLD Annual Meeting Advances GR-MD-02 Into Phase 2... Nov 09 2014
    After hep C cure, companies target next big liver disease market Nov 09 2014
    Kingsford’s Wilkins Recommends Shorting Drugmaker Galctin Nov 06 2014
    Galectin Therapeutics' Abstract Accepted as Oral Presentation at The Liver Meeting(R), Annual... Oct 01 2014
    Trick Play: Beware of Insiders Trying to 'Paint the Tape' Sep 30 2014
    GALECTIN 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General... Sep 26 2014
    EQUITY ALERT: Rosen Law Firm Reminds Galectin Therapeutics, Inc. Investors of Important September... Sep 26 2014
    Galectin Therapeutics Elects Gilbert S. Omenn, M.D., Ph.D., a Leading Cancer Researcher, to Its... Sep 24 2014
    GALECTIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 24 2014
    SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Reminds Investors of Class Action Against Galectin... Sep 22 2014
    SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Sep 22 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK